Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Why Earlier Conversations About Long-Acting Injectables for Schizophrenia Matter

(MedPage Today) -- Bryce Reynolds, MD, at Carolina Outreach is a paid partner of Teva Pharmaceuticals. One of the biggest paradoxes in schizophrenia care is that some of our most established treatment options are still among the least utilized...

Why Earlier Conversations About Long-Acting Injectables for Schizophrenia Matter

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 30 September →